Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion type Assertion NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_head.
- NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion description "[The TLR9-mediated activation of the vertebrate immune system suggests using such TLR9 agonists as effective vaccine adjuvants for infectious disease, and for the treatment of cancer and asthma/allergy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_provenance.
- NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion evidence source_evidence_literature NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_provenance.
- NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion SIO_000772 18020622 NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_provenance.
- NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion wasDerivedFrom befree-20140225 NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_provenance.
- NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_assertion wasGeneratedBy ECO_0000203 NP848260.RADEEQW-EyoBY0p3RQU1GidYwGjrBR_97UjpLelE0BiZE130_provenance.